Tag: Behcet s disease

First developed in the 1980s, rebamipide is a gastroprotective drug widely used in Asia, and for good reason: it has broad applications beyond its primary role. But specifically, what is rebamipide used to treat?

Behçet's disease, a rare inflammatory disorder, has a global prevalence estimated at 10.3 per 100,000 people [1.7.6]. Answering 'What is the drug of choice for Behçet's disease?' is complex, as no single medication is universally effective; treatment is tailored to the specific organ systems involved and symptom severity [1.3.3].

Developed in the 1980s, rebamipide is a gastroprotective drug extensively used in Asia for its unique ability to promote mucosal healing and defense. It offers a different approach to managing gastrointestinal conditions compared to traditional acid-suppressing agents, targeting the quality of tissue repair rather than just acid reduction.